<?xml version="1.0" encoding="UTF-8"?>

<rss xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd" version="2.0">

 

<channel>

<ttl>60</ttl>

<title>Clinical Care Options Oncology - Video Podcast</title>

<link>http://clinicaloptions.com/oncology.aspx</link>

<language>en-us</language>

<copyright>&#x2117; &amp; &#xA9; 2006 Clinical Care Options</copyright>

<itunes:subtitle>CCO is your best source for the newest oncology and hematology treatment data.</itunes:subtitle>

<itunes:author>Clinical Care Options</itunes:author>

<itunes:summary>Video education programs and slide presentations for oncologists and hematologists</itunes:summary>

<itunes:owner>

<itunes:name>Clinical Care Options Oncology Video Podcast</itunes:name>

<itunes:email>vkeane@clinicaloptions.com</itunes:email>

</itunes:owner>

<itunes:image href="http://images.clinicaloptions.com/images/podcast/ONC_podcast_logo_video.jpg" />

<itunes:category text="Science &amp; Medicine">
	<itunes:category text="Medicine" />
	</itunes:category>


<item>
<title>Ramaswamy Govindan, MD - Lung Cancer</title>
<itunes:author>Clinical Care Options</itunes:author>
<itunes:subtitle>CCO Expert Highlights from the 2008 Clinical Oncology Meeting</itunes:subtitle>
<itunes:summary>Ramaswamy Govindan, MD, examines the results of the phase III FLEX trial of cetuximab added to cisplatin/vinorelbine chemotherapy in advanced non-small-cell lung cancer along with other key clinical trial data presented in Chicago.</itunes:summary>
<enclosure url="http://clinicaloptions.com/onc_podcast_video_clinonc2008_lung.m4v" length="103052238" type="video/mp4" />
<guid>http://clinicaloptions.com/onc_podcast_video_clinonc2008_lung.m4v</guid>
<pubDate>Thu, 03 Jul 2008 17:00:00 GMT</pubDate>
<itunes:duration>08:37</itunes:duration>
<itunes:keywords>lung cancer, oncology, Govindan</itunes:keywords>
</item> 


<item>
<title>Richard M. Goldberg, MD - Gastrointestinal Cancers</title>
<itunes:author>Clinical Care Options</itunes:author>
<itunes:subtitle>CCO Expert Highlights from the 2008 Clinical Oncology Meeting</itunes:subtitle>
<itunes:summary>Richard M. Goldberg, MD, reviews key developments in colorectal cancer, including new clinical trial results in adjuvant treatment and therapy of metastatic disease, and new insights into molecular markers for prediction of response to biologic therapy.</itunes:summary>
<enclosure url="http://clinicaloptions.com/onc_podcast_video_clinonc2008_gastro.m4v" length="107042829" type="video/mp4" />
<guid>http://clinicaloptions.com/onc_podcast_video_clinonc2008_gastro.m4v</guid>
<pubDate>Tue, 01 Jul 2008 17:00:00 GMT</pubDate>
<itunes:duration>8:57</itunes:duration>
<itunes:keywords>gastrointestinal cancers, oncology, Goldberg</itunes:keywords>
</item> 


<item>
<title>Brian I. Rini, MD -  Genitourinary Cancers</title>
<itunes:author>Clinical Care Options</itunes:author>
<itunes:subtitle>CCO Expert Highlights from the 2008 Clinical Oncology Meeting</itunes:subtitle>
<itunes:summary>Brian I. Rini, MD, highlights the clinical advances being made for improving outcomes in patients with metastatic renal cell carcinoma, and prostate, bladder, and testicular cancers.</itunes:summary>
<enclosure url="http://clinicaloptions.com/onc_podcast_video_clinonc2008_genitour.m4v" length="93952740" type="video/mp4" />
<guid>http://clinicaloptions.com/onc_podcast_video_clinonc2008_genitour.m4v</guid>
<pubDate>Mon, 30 Jun 2008 17:00:00 GMT</pubDate>
<itunes:duration>7:52</itunes:duration>
<itunes:keywords>genitourinary cancer,oncology,Rini</itunes:keywords>
</item> 


 
 <item>
 <title>Kathy D. Miller, MD - Breast Cancer</title>
 <itunes:author>Clinical Care Options</itunes:author>
 <itunes:subtitle>CCO Expert Highlights from the 2008 Clinical Oncology Meeting</itunes:subtitle>
 <itunes:summary>Kathy D. Miller, MD, provides an update on the top issues in adjuvant therapy including hormone therapy, bone loss treatments, and vitamin D status. She also discusses the impact of biologic agents targeting the VEGF and EGF receptors on therapy for metastatic disease.</itunes:summary>
 <enclosure url="http://clinicaloptions.com/onc_podcast_video_clinonc2008_breast.m4v" length="145044665" type="video/mp4" />
 <guid>http://clinicaloptions.com/onc_podcast_video_clinonc2008_breast.m4v</guid>
 <pubDate>Fri, 27 Jun 2008 17:00:00 GMT</pubDate>
 <itunes:duration>12:03</itunes:duration>
 <itunes:keywords>breast cancer,oncology,miller</itunes:keywords>
 </item> 
 

  <item>
         
         <title>Kenneth Anderson, MD  - Hematology 2005 Report on Multiple Myeloma</title>
         
         <itunes:author>Clinical Care Options</itunes:author>
         
         <itunes:subtitle>A CCO Expert Recap of the Hematology meeting in Atlanta.</itunes:subtitle>
         
         <itunes:summary>Listen to Kenneth Anderson, MD, review slides of key data from the Atlanta meeting.</itunes:summary>
         
         <enclosure url="http://clinicaloptions.com/onc_podcast_video_er_heme05.mp4" length="39044696" type="video/mp4" />
         
         
         
         <guid>http://clinicaloptions.com/onc_podcast_video_er_heme05.mp4</guid>
         
         <pubDate>Wed, 19 Apr 2006 17:00:00 GMT</pubDate>
         
         <itunes:duration>34:30</itunes:duration>
         
         <itunes:keywords>hematology, multiple myeloma, Anderson</itunes:keywords>
        
  </item>

<item>
            
            <title>Hagop M. Kantarjian, MD - Expert Highlight: Acute Leukemias and Myelodysplastic Syndromes</title>
            
            <itunes:author>Clinical Care Options</itunes:author>
            
            <itunes:subtitle>CCO Expert Highlights from the 2008 Hematology Meeting</itunes:subtitle>
            
            <itunes:summary>Hagop Kantarjian, MD, provides an update of presentations on acute myeloid leukemia, myelodysplastic syndromes, and myelofibrosis.</itunes:summary>
            
            <enclosure url="http://clinicaloptions.com/onc_podcast_video_hematology2008_kantarjian.m4v" length="68243456" type="audio/x-m4v" />
            
            
            
            <guid>http://clinicaloptions.com/onc_podcast_video_hematology2008_kantarjian.m4v</guid>
            
            <pubDate>Mon, 29 Dec 2008 17:00:00 GMT</pubDate>
            
            <itunes:duration>9:16</itunes:duration>
            
            <itunes:keywords>hematology, leukemia, Kantarjian</itunes:keywords>
            
  </item>


<item>
            
            <title>Kanti Rai, MD - Expert Highlight: Updates in CLL</title>
            
            <itunes:author>Clinical Care Options</itunes:author>
            
            <itunes:subtitle>CCO Expert Highlights from the 2008 Hematology Meeting</itunes:subtitle>
            
            <itunes:summary>Kanti Rai, MD, discusses updates in CLL therapies, including lenalidomide in the frontline setting, FCR data from the REACH trial, and the novel agent ofatumumab.</itunes:summary>
            
            <enclosure url="http://clinicaloptions.com/onc_podcast_video_hematology2008_rai.m4v" length="94208000" type="audio/x-m4v" />
            
            
            
            <guid>http://clinicaloptions.com/onc_podcast_video_hematology2008_rai.m4v</guid>
            
            <pubDate>Mon, 29 Dec 2008 17:00:00 GMT</pubDate>
            
            <itunes:duration>12:49</itunes:duration>
            
            <itunes:keywords>hematology, CLL, Rai</itunes:keywords>
            
  </item>
 
 <item>
            
            <title>David P. Steensma, MD - Expert Highlight: ESAs in Cancer</title>
            
            <itunes:author>Clinical Care Options</itunes:author>
            
            <itunes:subtitle>CCO Expert Highlights from the 2008 Hematology Meeting</itunes:subtitle>
            
            <itunes:summary>David P. Steensma, MD, describes a patient-level meta-analysis on the effect of ESAs on the survival of cancer patients and the implications for patient care.</itunes:summary>
            
            <enclosure url="http://clinicaloptions.com/onc_podcast_video_hematology2008_Steensma.m4v" length="62066688" type="audio/x-m4v" />
            
            
            
            <guid>http://clinicaloptions.com/onc_podcast_video_hematology2008_Steensma.m4v</guid>
            
            <pubDate>Mon, 29 Dec 2008 17:00:00 GMT</pubDate>
            
            <itunes:duration>8:28</itunes:duration>
            
            <itunes:keywords>hematology, ESAs, Steensma</itunes:keywords>
            
  </item>

 <item>
            
            <title>Steven Bernstein, MD - Expert Highlight: Lymphomas</title>
            
            <itunes:author>Clinical Care Options</itunes:author>
            
            <itunes:subtitle>CCO Expert Highlights from the 2008 Hematology Meeting</itunes:subtitle>
            
            <itunes:summary>Steven Bernstein, MD, summarizes the clinical advances in improving outcomes in patients with non-Hodgkins lymphomas, in particular T-cell lymphomas and mantle cell lymphomas.</itunes:summary>
            
            <enclosure url="http://clinicaloptions.com/onc_podcast_video_hematology2008_Bernstein.m4v" length="52953088" type="audio/x-m4v" />
            
            
            
            <guid>http://clinicaloptions.com/onc_podcast_video_hematology2008_Bernstein.m4v</guid>
            
            <pubDate>Mon, 29 Dec 2008 17:00:00 GMT</pubDate>
            
            <itunes:duration>7:13</itunes:duration>
            
            <itunes:keywords>hematology, Lymphoma, Bernstein</itunes:keywords>
            
  </item>
 
  <item>
            
            <title>Sagar Lonial, MD - Expert Highlight: Updates in Multiple Myeloma</title>
            
            <itunes:author>Clinical Care Options</itunes:author>
            
            <itunes:subtitle>CCO Expert Highlights from the 2008 Hematology Meeting</itunes:subtitle>
            
            <itunes:summary>Sagar Lonial, MD, summarizes the key data presented in San Francisco in multiple myeloma, including updated results from the VISTA trial and from studies in novel agents.</itunes:summary>
            
            <enclosure url="http://clinicaloptions.com/onc_podcast_video_hematology2008_Lonial.m4v" length="38268928" type="audio/x-m4v" />
            
            
            
            <guid>http://clinicaloptions.com/onc_podcast_video_hematology2008_Lonial.m4v</guid>
            
            <pubDate>Mon, 29 Dec 2008 17:00:00 GMT</pubDate>
            
            <itunes:duration>5:12</itunes:duration>
            
            <itunes:keywords>hematology, Multiple Myeloma, Lonial</itunes:keywords>
            
  </item>
 

</channel>

</rss>

